The Aicardi-Goutières Syndrome Gene Panel by NGS is a specialized molecular test designed to detect genetic variants associated with Aicardi-Goutières Syndrome (AGS). Metropolis Healthcare performs this analysis using next-generation sequencing to evaluate multiple AGS-related genes with high accuracy. The test helps confirm diagnosis, guide clinical decisions, and support genetic counseling. It is especially valuable when symptoms suggest an inherited neuro-inflammatory or autoimmune condition.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0163
Frequently Asked Questions (FAQ's):
What does this test include at Metropolis Healthcare?
It includes next-generation sequencing of genes known to be linked with Aicardi-Goutières Syndrome.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced NGS technology to analyze DNA extracted from an EDTA blood sample.
Who should take this test at Metropolis Healthcare?
Infants, children, or adults with suspected AGS, unexplained neuro-inflammation, or a family history of the disorder.
What sample is required at Metropolis Healthcare?
A blood sample collected in an EDTA tube for DNA extraction and sequencing.
How does this test help clinicians at Metropolis Healthcare?
It confirms the genetic cause of AGS, supports prognosis, and guides appropriate management or genetic counseling.
Is any preparation needed before visiting Metropolis Healthcare?
No fasting or preparation is required; only routine blood collection is needed.
How long does the test take at Metropolis Healthcare?
Turnaround time typically spans several days to weeks due to detailed sequencing and analysis.
When will I receive the report from Metropolis Healthcare?
Reports are provided as per the molecular diagnostics schedule, along with expert genetic interpretation.